NASDAQ:LENS - Presbia Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.30 +0.08 (+3.60 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$2.30
Today's Range$2.30 - $2.33
52-Week Range$1.86 - $7.14
Volume2,200 shs
Average Volume24,572 shs
Market Capitalization$39.04 million
P/E RatioN/A
Dividend YieldN/A
Beta0.11

About Presbia (NASDAQ:LENS)

Presbia logoPresbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in South Korea, Australia, New Zealand, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.

Receive LENS News and Ratings via Email

Sign-up to receive the latest news and ratings for LENS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:LENS
CUSIPN/A
Phone353-551-1487

Debt

Debt-to-Equity RatioN/A
Current Ratio0.59
Quick Ratio0.57

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales3,937.60
Cash FlowN/A
Price / CashN/A
Book Value$0.05 per share
Price / Book46.00

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-16,990,000.00
Net MarginsN/A
Return on Equity-267.09%
Return on Assets-177.37%

Miscellaneous

Employees24
Outstanding Shares17,120,000

Presbia (NASDAQ:LENS) Frequently Asked Questions

What is Presbia's stock symbol?

Presbia trades on the NASDAQ under the ticker symbol "LENS."

How were Presbia's earnings last quarter?

Presbia PLC (NASDAQ:LENS) released its quarterly earnings data on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to analyst estimates of $0.04 million. View Presbia's Earnings History.

When is Presbia's next earnings date?

Presbia is scheduled to release their next quarterly earnings announcement on Friday, August, 10th 2018. View Earnings Estimates for Presbia.

What price target have analysts set for LENS?

2 Wall Street analysts have issued twelve-month price objectives for Presbia's shares. Their forecasts range from $7.00 to $10.00. On average, they expect Presbia's stock price to reach $8.50 in the next year. View Analyst Ratings for Presbia.

Who are some of Presbia's key competitors?

Who are Presbia's key executives?

Presbia's management team includes the folowing people:
  • Mr. Richard T. Fogarty, Chief Accounting Officer, VP of Fin. & Sec. (Age 67)
  • Mr. Vladimir Feingold, Consultant (Age 69)
  • Mr. Mark T. Yung, CEO & Chairman
  • Ms. Casey Jean Lind, Chief Operating Officer
  • Ms. Marie Cha, Director of Direct Response Marketing

When did Presbia IPO?

(LENS) raised $50 million in an IPO on Thursday, January 29th 2015. The company issued 4,200,000 shares at a price of $11.00-$13.00 per share. Jefferies served as the underwriter for the IPO.

Has Presbia been receiving favorable news coverage?

Media headlines about LENS stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Presbia earned a media sentiment score of 0.17 on Accern's scale. They also gave media stories about the medical instruments supplier an impact score of 46.36 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Presbia?

Shares of LENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Presbia's stock price today?

One share of LENS stock can currently be purchased for approximately $2.30.

How big of a company is Presbia?

Presbia has a market capitalization of $39.04 million and generates $10,000.00 in revenue each year. Presbia employs 24 workers across the globe.

How can I contact Presbia?

Presbia's mailing address is SANDYFORD OFFICE CENTRE SUITE 7 17 CORRIG ROAD, DUBLIN 18 L2, . The medical instruments supplier can be reached via phone at 353-551-1487.


MarketBeat Community Rating for Presbia (LENS)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  196
MarketBeat's community ratings are surveys of what our community members think about Presbia and other stocks. Vote "Outperform" if you believe LENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LENS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Presbia (NASDAQ:LENS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Presbia in the last 12 months. Their average twelve-month price target is $8.50, suggesting that the stock has a possible upside of 269.57%. The high price target for LENS is $10.00 and the low price target for LENS is $7.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.50$9.6667$9.6667$11.3333
Price Target Upside: 269.57% upside107.89% upside107.89% upside116.50% upside

Presbia (NASDAQ:LENS) Consensus Price Target History

Price Target History for Presbia (NASDAQ:LENS)

Presbia (NASDAQ:LENS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/20/2017HC WainwrightReiterated RatingBuy$7.00MediumView Rating Details
10/6/2017Jefferies GroupReiterated RatingBuy$11.00 ➝ $10.00N/AView Rating Details
5/22/2017Rodman & RenshawLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00MediumView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Presbia (NASDAQ:LENS) Earnings History and Estimates Chart

Earnings by Quarter for Presbia (NASDAQ:LENS)

Presbia (NASDAQ:LENS) Earnings Estimates

2018 EPS Consensus Estimate: ($1.24)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.24)($0.24)($0.24)
Q2 20181($0.26)($0.26)($0.26)
Q3 20181($0.35)($0.35)($0.35)
Q4 20181($0.39)($0.39)($0.39)

Presbia (NASDAQ LENS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2018        
8/11/2017Q2 2017($0.27)($0.27)ViewN/AView Earnings Details
5/12/2017Q1 2017($0.15)($0.32)$0.01 millionViewN/AView Earnings Details
3/29/2017Q4 2016($0.29)ViewN/AView Earnings Details
11/4/2016Q3 2016($0.32)$0.01 millionViewN/AView Earnings Details
8/12/2016Q3 2016($0.25)($0.32)$0.04 million$0.01 millionViewN/AView Earnings Details
5/4/2016Q1 2016($0.28)($0.28)ViewN/AView Earnings Details
3/25/2016Q2($0.2550)($0.29)$0.04 million$0.03 millionViewN/AView Earnings Details
11/13/2015Q3 2015($0.41)($0.37)$0.01 million$0.01 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.29)($0.40)$0.40 million$0.04 millionViewN/AView Earnings Details
5/15/2015Q1 2015($0.25)($0.39)$0.10 million$0.07 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Presbia (NASDAQ:LENS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Presbia (NASDAQ LENS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 74.70%
Institutional Ownership Percentage: 15.51%
Insider Trading History for Presbia (NASDAQ:LENS)
Institutional Ownership by Quarter for Presbia (NASDAQ:LENS)

Presbia (NASDAQ LENS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/17/2016Gerald FarrellDirectorBuy5,000$4.65$23,250.0021,568View SEC Filing  
12/17/2015Richard S ResslerDirectorBuy500$6.00$3,000.003,175,181View SEC Filing  
12/10/2015Richard S. ResslerDirectorBuy499$6.00$2,994.003,174,681View SEC Filing  
12/2/2015Richard S. ResslerDirectorBuy1,300$5.86$7,618.003,174,182View SEC Filing  
11/25/2015Randy H ThurmanChairmanBuy1,833$5.45$9,989.8519,396View SEC Filing  
11/24/2015Richard S ResslerDirectorBuy2,300$4.97$11,431.003,172,882View SEC Filing  
11/20/2015Richard FogartyCAOBuy1,000$4.00$4,000.002,000View SEC Filing  
11/19/2015Robert J. CresciDirectorBuy10,000$3.97$39,700.0019,270View SEC Filing  
11/19/2015Zohar LoshitzerInsiderBuy5,500$4.00$22,000.00271,516View SEC Filing  
11/18/2015Todd CooperCEOBuy7,500$3.99$29,925.007,500View SEC Filing  
5/26/2015Richard FogartyCAOBuy1,000$8.60$8,600.00View SEC Filing  
5/20/2015Randy H ThurmanChairmanBuy11,110$8.96$99,545.60View SEC Filing  
2/3/2015Richard S ResslerDirectorBuy500,000$10.00$5,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Presbia (NASDAQ LENS) News Headlines

Source:
DateHeadline
Zacks: Brokerages Set $8.50 Target Price for Presbia PLC (LENS)Zacks: Brokerages Set $8.50 Target Price for Presbia PLC (LENS)
www.americanbankingnews.com - May 24 at 3:23 PM
Zacks: Analysts Set $8.50 Target Price for Presbia (LENS)Zacks: Analysts Set $8.50 Target Price for Presbia (LENS)
www.americanbankingnews.com - May 5 at 3:12 PM
Presbia (LENS) Raised to "Hold" at ValuEnginePresbia (LENS) Raised to "Hold" at ValuEngine
www.americanbankingnews.com - May 3 at 12:39 AM
-$0.21 Earnings Per Share Expected for Presbia (LENS) This Quarter-$0.21 Earnings Per Share Expected for Presbia (LENS) This Quarter
www.americanbankingnews.com - April 30 at 1:14 AM
Reviewing Presbia (LENS) & Cellect Biotechnology (APOP)Reviewing Presbia (LENS) & Cellect Biotechnology (APOP)
www.americanbankingnews.com - April 21 at 11:30 AM
Zacks: Presbia (LENS) Given Consensus Rating of "Strong Buy" by AnalystsZacks: Presbia (LENS) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - April 20 at 5:24 PM
Presbia (LENS) Stock Rating Upgraded by Zacks Investment ResearchPresbia (LENS) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 16 at 4:48 PM
Zacks: Brokerages Expect Presbia (LENS) to Announce -$0.21 Earnings Per ShareZacks: Brokerages Expect Presbia (LENS) to Announce -$0.21 Earnings Per Share
www.americanbankingnews.com - April 13 at 3:12 AM
Presbia (LENS) Downgraded by Zacks Investment ResearchPresbia (LENS) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 7 at 1:43 PM
Zacks: Presbia (LENS) Given $8.50 Average Target Price by AnalystsZacks: Presbia (LENS) Given $8.50 Average Target Price by Analysts
www.americanbankingnews.com - April 5 at 3:08 AM
Presbia Announces New Management AppointmentsPresbia Announces New Management Appointments
finance.yahoo.com - February 21 at 9:52 AM
Critical Comparison: Presbia (LENS) vs. Pulse Biosciences (PLSE)Critical Comparison: Presbia (LENS) vs. Pulse Biosciences (PLSE)
www.americanbankingnews.com - February 20 at 4:23 PM
Derma Sciences (DSCI) vs. Presbia (LENS) Head-To-Head AnalysisDerma Sciences (DSCI) vs. Presbia (LENS) Head-To-Head Analysis
www.americanbankingnews.com - February 19 at 1:16 AM
 Presbia PLC (LENS) Receives Average Rating of "Strong Buy" from Brokerages Presbia PLC (LENS) Receives Average Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - February 5 at 1:14 AM
Presbia (LENS) vs. Cerner (CERN) Critical AnalysisPresbia (LENS) vs. Cerner (CERN) Critical Analysis
www.americanbankingnews.com - January 27 at 1:06 PM
ETFs with exposure to Presbia Plc : January 1, 2018ETFs with exposure to Presbia Plc : January 1, 2018
finance.yahoo.com - January 1 at 4:44 PM
Contrasting Presbia (LENS) and Fulgent Genetics (FLGT)Contrasting Presbia (LENS) and Fulgent Genetics (FLGT)
www.americanbankingnews.com - January 1 at 9:26 AM
Presbia Plc :LENS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017Presbia Plc :LENS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
finance.yahoo.com - December 27 at 2:59 PM
Zacks: Brokerages Set $11.00 Price Target for Presbia PLC (LENS)Zacks: Brokerages Set $11.00 Price Target for Presbia PLC (LENS)
www.americanbankingnews.com - December 21 at 7:48 AM
HC Wainwright Reiterates "Buy" Rating for Presbia (LENS)HC Wainwright Reiterates "Buy" Rating for Presbia (LENS)
www.americanbankingnews.com - December 20 at 7:20 PM
ETFs with exposure to Presbia Plc : December 20, 2017ETFs with exposure to Presbia Plc : December 20, 2017
finance.yahoo.com - December 20 at 4:48 PM
Zacks: Presbia PLC (LENS) Given Consensus Rating of "Strong Buy" by BrokeragesZacks: Presbia PLC (LENS) Given Consensus Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - December 17 at 1:30 AM
Presbia Announces Board and Management Changes and Financing Proposal to Operate Through to the End of 2018Presbia Announces Board and Management Changes and Financing Proposal to Operate Through to the End of 2018
finance.yahoo.com - December 14 at 5:20 PM
Financial Contrast: Viewray (VRAY) versus Presbia (LENS)Financial Contrast: Viewray (VRAY) versus Presbia (LENS)
www.americanbankingnews.com - December 10 at 9:08 PM
Comparing Mazor Robotics (MZOR) and Presbia (LENS)Comparing Mazor Robotics (MZOR) and Presbia (LENS)
www.americanbankingnews.com - December 4 at 12:02 PM
Zacks: Brokerages Anticipate Presbia PLC (LENS) Will Post Earnings of -$0.26 Per ShareZacks: Brokerages Anticipate Presbia PLC (LENS) Will Post Earnings of -$0.26 Per Share
www.americanbankingnews.com - November 27 at 9:14 AM
Brokerages Anticipate Presbia PLC (LENS) to Post ($0.26) Earnings Per ShareBrokerages Anticipate Presbia PLC (LENS) to Post ($0.26) Earnings Per Share
www.americanbankingnews.com - November 26 at 3:18 PM
ETFs with exposure to Presbia Plc : November 21, 2017ETFs with exposure to Presbia Plc : November 21, 2017
finance.yahoo.com - November 22 at 1:50 AM
Analyzing Presbia PLC (LENS) & Digirad Corporation (DRAD)Analyzing Presbia PLC (LENS) & Digirad Corporation (DRAD)
www.americanbankingnews.com - November 16 at 10:18 AM
Presbia PLC (LENS) and Hologic (HOLX) Head-To-Head ContrastPresbia PLC (LENS) and Hologic (HOLX) Head-To-Head Contrast
www.americanbankingnews.com - October 14 at 8:14 AM
Presbia PLC to Post Q1 2018 Earnings of ($0.24) Per Share, Jefferies Group Forecasts (LENS)Presbia PLC to Post Q1 2018 Earnings of ($0.24) Per Share, Jefferies Group Forecasts (LENS)
www.americanbankingnews.com - October 9 at 4:48 AM
Presbia PLCs (LENS) "Buy" Rating Reiterated at Jefferies Group LLCPresbia PLC's (LENS) "Buy" Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - October 6 at 1:46 PM
ECYT On Fire After ABX Deal, Rigels ITP Drug Skips Panel Review, MCRB On WatchECYT On Fire After ABX Deal, Rigel's ITP Drug Skips Panel Review, MCRB On Watch
www.rttnews.com - October 2 at 10:01 PM
Should You Be Holding Presbia PLC (LENS) Right Now?Should You Be Holding Presbia PLC (LENS) Right Now?
finance.yahoo.com - October 2 at 10:01 PM
Head-To-Head Review: Presbia PLC (LENS) versus Alliance HealthCare Services (AIQ)Head-To-Head Review: Presbia PLC (LENS) versus Alliance HealthCare Services (AIQ)
www.americanbankingnews.com - September 25 at 4:10 PM
Head to Head Survey: Presbia PLC (LENS) vs. The CompetitionHead to Head Survey: Presbia PLC (LENS) vs. The Competition
www.americanbankingnews.com - September 20 at 2:22 PM
Analyzing Presbia PLC (LENS) & The CompetitionAnalyzing Presbia PLC (LENS) & The Competition
www.americanbankingnews.com - September 16 at 4:24 AM
Presbia to Participate in Rodman & Renshaw 19th Annual Global Investment ConferencePresbia to Participate in Rodman & Renshaw 19th Annual Global Investment Conference
finance.yahoo.com - September 8 at 1:16 AM
ETFs with exposure to Presbia Plc : August 1, 2017ETFs with exposure to Presbia Plc : August 1, 2017
finance.yahoo.com - August 2 at 3:04 AM
ETFs with exposure to Presbia Plc : July 3, 2017ETFs with exposure to Presbia Plc : July 3, 2017
finance.yahoo.com - July 3 at 7:51 PM
6:15 pm Presbia extends shareholder rights offering for up to 4.5 mln ordinary shares to March 8 from February 236:15 pm Presbia extends shareholder rights offering for up to 4.5 mln ordinary shares to March 8 from February 23
us.rd.yahoo.com - February 23 at 11:16 PM
PRESBIA PLC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsPRESBIA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
us.rd.yahoo.com - February 22 at 6:24 PM
Presbia Announces Extension of Rights OfferingPresbia Announces Extension of Rights Offering
uk.finance.yahoo.com - February 22 at 6:24 PM
Form 424B4 Presbia PLCForm 424B4 Presbia PLC
www.streetinsider.com - January 27 at 8:27 PM
Presbia Announces Price and Key Dates Related to Rights OfferingPresbia Announces Price and Key Dates Related to Rights Offering
uk.finance.yahoo.com - January 26 at 8:01 PM
Presbia (LENS) Unit Completes Acquisition of Neoptics AGPresbia (LENS) Unit Completes Acquisition of Neoptics AG
www.streetinsider.com - August 22 at 10:31 AM
PRESBIA PLC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersPRESBIA PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - August 10 at 8:54 AM
PRESBIA PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or DispositionPRESBIA PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition
biz.yahoo.com - August 8 at 6:09 PM
Presbia to Participate in the 2016 Australasian Society of Cataract and Refractive Surgeons 20 th Annual ConferencePresbia to Participate in the 2016 Australasian Society of Cataract and Refractive Surgeons 20 th Annual Conference
www.businesswire.com - July 12 at 10:20 AM
Heres Why Presbia Is Worth $14/Share, Despite Plummeting MondayHere's Why Presbia Is Worth $14/Share, Despite Plummeting Monday
feeds.benzinga.com - May 23 at 1:49 PM

SEC Filings

Presbia (NASDAQ:LENS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Presbia (NASDAQ:LENS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Presbia (NASDAQ LENS) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.